Trump administration officials announce PTSD research funding for psychedelic drug ibogaine
Summary
Federal officials on Thursday announced new funding to explore the medical potential of ibogaine, a controversial psychedelic drug championed by veterans, conservative lawmakers and podcasters aligned with President Donald Trump. Covered by 3 outlets: 2 lean left, 1 are centre.
Automated summary picked from the outlets' own descriptions.
Who is covering this
-
Trump Officials Will Fund New Research on Controversial Psychedelic Drug Ibogaine
(MedPage Today) -- Federal officials on Thursday announced new funding to explore the medical potential of ibogaine, a controversial psychedelic drug championed by veterans, conservative lawmakers, and podcasters aligned with President Donald Trump...
-
WATCH: Trump administration officials announce PTSD research funding for psychedelic drug ibogaine
Federal officials on Thursday announced new funding to explore the medical potential of ibogaine, a controversial psychedelic drug championed by veterans, conservative lawmakers and podcasters aligned with President Donald Trump.
-
Trump administration will fund new research on controversial psychedelic drug ibogaine
Federal officials say there's new funding to study the medical potential of a powerful psychedelic
Related stories
Trump administration promised farmers $15 billion in weeks before midterms
Trump names Stephen Miller his next chief of staff after major Republican midterm losses
Trump says he's asked UFC's Dana White to be his press secretary
China denies allegations of spy operation targeting Nvidia CEO
U.S. launches new attacks on Iranian targets days after Netanyahu pressed Trump for more strikes
Comments
Comments need JavaScript.